ANTIMICROBIAL STEWARDSHIP: STRATEGIES TO COMBAT DRUG RESISTANCE AND IMPROVE PATIENT OUTCOMES

Antimicrobial resistance (AMR) is a developing worldwide health issue that reduces the effectiveness of antimicrobial medicines, increasing morbidity, mortality, and healthcare expenditures. The overuse and misuse of antimicrobials in both human and veterinary medicine has hastened the emergence of resistant bacteria. antibiotic stewardship (AMS) initiatives have evolved as an important approach to combat AMR by optimizing antibiotic use, assuring appropriate dosing, and reducing resistance. These initiatives use a multimodal approach, encompassing leadership support, formulary management, evidence-based prescribing recommendations, ongoing education, surveillance, and infection control measures. Antibiotic de-escalation, dosage modification, and therapy length are all AMS measures designed to limit needless antimicrobial exposure while improving patient outcomes. Despite the effectiveness of AMS programs, difficulties persist, particularly in resource-constrained areas, such as a lack of diagnostic tools, resistance from healthcare providers, and financial limitations. The impact of AMS programs includes lower mortality rates, shorter hospital stays, enhanced resistance profiles, and cost savings. The future of AMS programs depends on the incorporation of sophisticated technology such as artificial intelligence, quick diagnostics, genetic surveillance, and worldwide collaboration. These advances have the potential to further optimize antibiotic use while also addressing the global concern of antimicrobial resistance.